Highly active antiretroviral therapy in HIV-associated pulmonary hypertension [1]

Minerva Cardioangiologica

Volumn 53, Issue 2, 2005, Pages 153-154

  Barbaro, G ^a,d   Lucchini, A ^b   Barbarini, G ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ALT ONLUS   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; ECHOCARDIOGRAPHY; EXERCISE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PULMONARY HYPERTENSION; TREATMENT RESPONSE;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; MALE; PROSPECTIVE STUDIES;

EID: 33745374389     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Barbaro G. Reviewing the clinical aspects of HIV-associated pulmonary hypertension. J Respir Dis 2004;25:289-93.
2. Zuber JP, Calmy A, Evison JM, Hasse B, Schiffer V, Wagels T et al. Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 2004;38:1178-85.